N※N

MS Foundation CEO Teresa Younger Departs, Leaving Legacy of Progress

  //politics-government.news-articles.net/content/ .. -younger-departs-leaving-legacy-of-progress.html
  Published in Politics and Government on Tuesday, March 17th 2026 at 21:48 GMT by WSLS 10
      Locale: UNITED STATES

ROANOKE, Va. - March 18, 2026 - After years of dedicated service, Teresa Younger has concluded her tenure as CEO of the Multiple Sclerosis (MS) Foundation, leaving behind a legacy of impactful leadership and a strengthened commitment to the MS community. Her departure, announced earlier this month, signals a turning point for the organization, though it remains steadfast in its mission to create a world free of MS.

Younger's time at the helm has been marked by significant advancements across all facets of the Foundation's work. Under her guidance, the MS Foundation has not only expanded its research funding but also amplified its voice in crucial policy debates, and significantly enhanced the support systems available to individuals and families grappling with the complexities of MS. The doubling of research investment, confirmed in recent financial reports, reflects a strategic prioritization of scientific discovery, a core pillar of Younger's leadership.

"It's been an incredible journey, witnessing the resilience of the MS community and channeling their strength into tangible progress," Younger shared in a farewell interview. "We've celebrated breakthroughs in understanding the disease and developing new therapeutic approaches, but the fight is far from over. A cure remains the ultimate goal, and continued, focused research is paramount."

MS is a chronic, often disabling disease that affects the central nervous system. Its symptoms vary widely, ranging from mild numbness and fatigue to significant motor impairments and cognitive difficulties. The unpredictable nature of the disease and the lack of a definitive cure underscore the urgency of research and support efforts. The current estimate, as per the National MS Society, places the number of Americans living with MS at nearly one million, a figure that continues to rise, making advancements even more critical.

Younger's leadership extended beyond simply increasing funding. She actively fostered collaborative relationships with leading research institutions and pharmaceutical companies, facilitating the exchange of knowledge and accelerating the pace of innovation. A key initiative launched under her direction - the 'MS Pathways' program - focused on streamlining the clinical trial process, reducing barriers to participation for patients, and ensuring that research findings are rapidly translated into improved care. This initiative alone has reportedly increased patient enrollment in critical trials by 25% over the last two years.

Advocacy also formed a cornerstone of Younger's strategy. Recognizing that access to affordable healthcare and supportive services is essential for individuals with MS, she spearheaded campaigns at both the state and federal levels to advocate for policies that address these critical needs. These efforts culminated in the passage of the 'MS Access Act' in 2025, which expanded insurance coverage for disease-modifying therapies and provided funding for community-based support programs.

However, Younger readily acknowledged the constant challenges inherent in leading a non-profit organization. "The demand for services and resources consistently outpaces our capacity," she admitted. "We are entirely reliant on the generosity of individual donors, corporate sponsors, and the tireless commitment of our volunteers. Maintaining strong relationships with all stakeholders is absolutely vital." The Foundation's annual fundraising gala, consistently a sell-out event during her tenure, has become a crucial source of revenue, raising over $15 million annually.

Looking forward, Younger emphasized the importance of patient-centered care and the need to prioritize the voices of those living with MS. "Their experiences are the compass guiding our work," she stated. "We must listen to their stories, understand their challenges, and incorporate their perspectives into every aspect of our research and care delivery efforts. Their insights are invaluable, and often overlooked in traditional medical research."

The MS Foundation has initiated a comprehensive search for Younger's successor, aiming to find a leader who shares her passion for the MS community and her commitment to driving innovation. The organization has established a search committee comprised of board members, medical experts, and individuals living with MS, ensuring a diverse and inclusive selection process. The interim CEO, Dr. Eleanor Vance, a renowned neurologist specializing in MS, will oversee the transition while the search is underway. The Foundation remains resolute in its commitment to funding cutting-edge research, advocating for equitable access to care, and empowering individuals and families affected by MS, carrying forward the momentum established during Teresa Younger's impactful leadership.